Understanding the biological context of NS5A-host interactions in HCV infection: A network-based approach

Journal of Proteome Research

Volumn 12, Issue 6, 2013, Pages 2537-2551

  Tripathi, Lokesh P ^a   Kambara, Hiroto ^b   Chen, Yi An ^a   Nishimura, Yorihiro ^b   Moriishi, Kohji ^b   Okamoto, Toru ^b   Morita, Eiji ^b   Abe, Takayuki ^b   Mori, Yoshio ^b   Matsuura, Yoshiharu ^b   Mizuguchi, Kenji ^a,c  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

biological network analysis; HCV; host pathogen protein protein interactions; literature mining; NS5A; pathway enrichment analysis; siRNA knockdown; target discovery; TargetMine; yeast two hybrid

Indexed keywords

COMPLEMENTARY DNA; NONSTRUCTURAL PROTEIN 5A;

ARTICLE; CELL ADHESION; CELL ASSAY; CELL COMMUNICATION; CELL DEATH; CELL GROWTH; CELL TRANSPORT; ENDOPLASMIC RETICULUM; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; INTRACELLULAR SIGNALING; NEOPLASM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; TWO HYBRID SYSTEM; VIRUS CELL INTERACTION; VIRUS HYBRID; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84879330388     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3011217     Document Type: Article

References (119)

1. Dubuisson, J. Hepatitis C virus proteins World J. Gastroenterol. 2007, 13 (17) 2406-15
2. Moriishi, K.; Matsuura, Y. Host factors involved in the replication of hepatitis C virus Rev. Med. Virol. 2007, 17 (5) 343-54
3. Myrmel, H.; Ulvestad, E.; Asjo, B. The hepatitis C virus enigma APMIS 2009, 117 (5-6) 427-39
4. Tang, H.; Grise, H. Cellular and molecular biology of HCV infection and hepatitis Clin. Sci. 2009, 117 (2) 49-65
5. Pol, S.; Vallet-Pichard, A.; Corouge, M.; Mallet, V. O. Hepatitis C: epidemiology, diagnosis, natural history and therapy Contrib. Nephrol. 2012, 176, 1-9
6. Kuiken, C.; Simmonds, P. Nomenclature and numbering of the hepatitis C virus Methods Mol. Biol. 2009, 510, 33-53
7. Moradpour, D.; Penin, F.; Rice, C. M. Replication of hepatitis C virus Nat. Rev. Microbiol. 2007, 5 (6) 453-63
8. Love, R. A.; Brodsky, O.; Hickey, M. J.; Wells, P. A.; Cronin, C. N. Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus J. Virol. 2009, 83 (9) 4395-403
9. Yamasaki, L. H.; Arcuri, H. A.; Jardim, A. C.; Bittar, C.; de Carvalho-Mello, I. M.; Rahal, P. New insights regarding HCV-NS5A structure/function and indication of genotypic differences Virol. J. 2012, 9, 14
10. Appel, N.; Zayas, M.; Miller, S.; Krijnse-Locker, J.; Schaller, T.; Friebe, P.; Kallis, S.; Engel, U.; Bartenschlager, R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly PLoS Pathog. 2008, 4 (3) e1000035
11. Gale, M. J., Jr.; Korth, M. J.; Tang, N. M.; Tan, S. L.; Hopkins, D. A.; Dever, T. E.; Polyak, S. J.; Gretch, D. R.; Katze, M. G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein Virology 1997, 230 (2) 217-27
12. Ghosh, S.; Ahrens, W. A.; Phatak, S. U.; Hwang, S.; Schrum, L. W.; Bonkovsky, H. L. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes J. Viral Hepatitis 2011, 18 (10) e568-77
13. Gao, M.; Nettles, R. E.; Belema, M.; Snyder, L. B.; Nguyen, V. N.; Fridell, R. A.; Serrano-Wu, M. H.; Langley, D. R.; Sun, J. H.; O'Boyle, D. R., 2nd; Lemm, J. A.; Wang, C.; Knipe, J. O.; Chien, C.; Colonno, R. J.; Grasela, D. M.; Meanwell, N. A.; Hamann, L. G. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Nature 2010, 465 (7294) 96-100
14. Lee, C. Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy Arch. Pharmacal Res. 2011, 34 (9) 1403-7
15. Lemm, J. A.; O'Boyle, D., 2nd; Liu, M.; Nower, P. T.; Colonno, R.; Deshpande, M. S.; Snyder, L. B.; Martin, S. W.; St Laurent, D. R.; Serrano-Wu, M. H.; Romine, J. L.; Meanwell, N. A.; Gao, M. Identification of hepatitis C virus NS5A inhibitors J. Virol. 2010, 84 (1) 482-91
16. Lemon, S. M.; McKeating, J. A.; Pietschmann, T.; Frick, D. N.; Glenn, J. S.; Tellinghuisen, T. L.; Symons, J.; Furman, P. A. Development of novel therapies for hepatitis C Antiviral Res. 2010, 86 (1) 79-92
17. Fusco, D. N.; Chung, R. T. Novel therapies for hepatitis C: insights from the structure of the virus Annu. Rev. Med. 2012, 63, 373-87
18. Buhler, S.; Bartenschlager, R. New targets for antiviral therapy of chronic hepatitis C Liver Int. 2012, 32 (Suppl 1) 9-16
19. Sarrazin, C.; Hezode, C.; Zeuzem, S.; Pawlotsky, J. M. Antiviral strategies in hepatitis C virus infection J. Hepatol. 2012, 56 (Suppl) S88-S100
20. Wang, S.; Wu, X.; Pan, T.; Song, W.; Wang, Y.; Zhang, F.; Yuan, Z. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33 J. Gen. Virol. 2012, 93 (Pt 1) 83-92
21. Durmus Tekir, S.; Cakir, T.; Ulgen, K. O. Infection strategies of bacterial and viral pathogens through pathogen-human protein-protein interactions Front. Microbiol. 2012, 3, 46
22. de Chassey, B.; Navratil, V.; Tafforeau, L.; Hiet, M. S.; Aublin-Gex, A.; Agaugue, S.; Meiffren, G.; Pradezynski, F.; Faria, B. F.; Chantier, T.; Le Breton, M.; Pellet, J.; Davoust, N.; Mangeot, P. E.; Chaboud, A.; Penin, F.; Jacob, Y.; Vidalain, P. O.; Vidal, M.; Andre, P.; Rabourdin-Combe, C.; Lotteau, V. Hepatitis C virus infection protein network Mol. Syst. Biol. 2008, 4, 230
23. Tan, S. L.; Ganji, G.; Paeper, B.; Proll, S.; Katze, M. G. Systems biology and the host response to viral infection Nat. Biotechnol. 2007, 25 (12) 1383-9
24. Tripathi, L. P.; Kataoka, C.; Taguwa, S.; Moriishi, K.; Mori, Y.; Matsuura, Y.; Mizuguchi, K. Network based analysis of hepatitis C virus Core and NS4B protein interactions Mol. BioSyst. 2010, 6 (12) 2539-53
25. Friedel, C. C.; Haas, J. Virus-host interactomes and global models of virus-infected cells Trends Microbiol. 2011, 19 (10) 501-8
26. Tafforeau, L.; Rabourdin-Combe, C.; Lotteau, V. Virus-human cell interactomes Methods Mol. Biol. 2012, 812, 103-20
27. Aizaki, H.; Aoki, Y.; Harada, T.; Ishii, K.; Suzuki, T.; Nagamori, S.; Toda, G.; Matsuura, Y.; Miyamura, T. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample Hepatology 1998, 27 (2) 621-7
28. Hamamoto, I.; Nishimura, Y.; Okamoto, T.; Aizaki, H.; Liu, M.; Mori, Y.; Abe, T.; Suzuki, T.; Lai, M. M.; Miyamura, T.; Moriishi, K.; Matsuura, Y. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B J. Virol. 2005, 79 (21) 13473-82
29. Rebholz-Schuhmann, D.; Kirsch, H.; Arregui, M.; Gaudan, S.; Riethoven, M.; Stoehr, P. EBIMed-text crunching to gather facts for proteins from Medline Bioinformatics 2007, 23 (2) e237-44
30. Rebholz-Schuhmann, D.; Arregui, M.; Gaudan, S.; Kirsch, H.; Jimeno, A. Text processing through Web services: calling Whatizit Bioinformatics 2008, 24 (2) 296-8
31. Stark, C.; Breitkreutz, B. J.; Reguly, T.; Boucher, L.; Breitkreutz, A.; Tyers, M. BioGRID: a general repository for interaction datasets Nucleic Acids Res. 2006, 34 (Database issue) D535-9
32. Turner, B.; Razick, S.; Turinsky, A. L.; Vlasblom, J.; Crowdy, E. K.; Cho, E.; Morrison, K.; Donaldson, I. M.; Wodak, S. J. iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence Database 2010, 2010, baq023
33. Chen, Y. A.; Tripathi, L. P.; Mizuguchi, K. TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery PLoS One 2011, 6 (3) e17844
34. Cline, M. S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2007, 2 (10) 2366-82
35. Smoot, M. E.; Ono, K.; Ruscheinski, J.; Wang, P. L.; Ideker, T. Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 2011, 27 (3) 431-2
36. Assenov, Y.; Ramirez, F.; Schelhorn, S. E.; Lengauer, T.; Albrecht, M. Computing topological parameters of biological networks Bioinformatics 2008, 24 (2) 282-4
37. Lees, J.; Yeats, C.; Perkins, J.; Sillitoe, I.; Rentzsch, R.; Dessailly, B. H.; Orengo, C. Gene3D: a domain-based resource for comparative genomics, functional annotation and protein network analysis Nucleic Acids Res. 2012, 40 (Database issue) D465-71
38. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 2000, 25 (1) 25-9
39. Aoki-Kinoshita, K. F.; Kanehisa, M. Gene annotation and pathway mapping in KEGG Methods Mol. Biol. 2007, 396, 71-91
40. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate-A practical and powerful approach to multiple testing J. R. Stat. Soc. B 1995, 57 (1) 289-300
41. Noble, W. S. How does multiple testing correction work? Nat. Biotechnol. 2009, 27 (12) 1135-7
42. Okamoto, K.; Mori, Y.; Komoda, Y.; Okamoto, T.; Okochi, M.; Takeda, M.; Suzuki, T.; Moriishi, K.; Matsuura, Y. Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation J. Virol. 2008, 82 (17) 8349-61
43. Okamoto, T.; Omori, H.; Kaname, Y.; Abe, T.; Nishimura, Y.; Suzuki, T.; Miyamura, T.; Yoshimori, T.; Moriishi, K.; Matsuura, Y. A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication J. Virol. 2008, 82 (7) 3480-9
44. Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H. G.; Mizokami, M.; Bartenschlager, R.; Liang, T. J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 2005, 11 (7) 791-6
45. Taguwa, S.; Kambara, H.; Omori, H.; Tani, H.; Abe, T.; Mori, Y.; Suzuki, T.; Yoshimori, T.; Moriishi, K.; Matsuura, Y. Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway J. Virol. 2009, 83 (20) 10427-36
46. Kukihara, H.; Moriishi, K.; Taguwa, S.; Tani, H.; Abe, T.; Mori, Y.; Suzuki, T.; Fukuhara, T.; Taketomi, A.; Maehara, Y.; Matsuura, Y. Human VAP-C negatively regulates hepatitis C virus propagation J. Virol. 2009, 83 (16) 7959-69
47. Nanda, S. K.; Herion, D.; Liang, T. J. The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity Gastroenterology 2006, 130 (3) 794-809
48. Liu, A. W.; Cai, J.; Zhao, X. L.; Jiang, T. H.; He, T. F.; Fu, H. Q.; Zhu, M. H.; Zhang, S. H. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth Clin. Cancer Res. 2011, 17 (4) 710-20
49. Woodhouse, S. D.; Narayan, R.; Latham, S.; Lee, S.; Antrobus, R.; Gangadharan, B.; Luo, S.; Schroth, G. P.; Klenerman, P.; Zitzmann, N. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro Hepatology 2010, 52 (2) 443-53
50. MacPherson, J. I.; Sidders, B.; Wieland, S.; Zhong, J.; Targett-Adams, P.; Lohmann, V.; Backes, P.; Delpuech-Adams, O.; Chisari, F.; Lewis, M.; Parkinson, T.; Robertson, D. L. An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection PLoS One 2011, 6 (10) e25584
51. Yamashita, T.; Honda, M.; Kaneko, S. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection J. Gastroenterol. Hepatol. 2011, 26 (6) 960-4
52. Yu, H.; Kim, P. M.; Sprecher, E.; Trifonov, V.; Gerstein, M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics PLoS Comput. Biol. 2007, 3 (4) e59
53. Rasmussen, A. L.; Diamond, D. L.; McDermott, J. E.; Gao, X.; Metz, T. O.; Matzke, M. M.; Carter, V. S.; Belisle, S. E.; Korth, M. J.; Waters, K. M.; Smith, R. D.; Katze, M. G. Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis J. Virol. 2011, 85 (22) 11646-54
54. Diamond, D. L.; Krasnoselsky, A. L.; Burnum, K. E.; Monroe, M. E.; Webb-Robertson, B. J.; McDermott, J. E.; Yeh, M. M.; Dzib, J. F.; Susnow, N.; Strom, S.; Proll, S. C.; Belisle, S. E.; Purdy, D. E.; Rasmussen, A. L.; Walters, K. A.; Jacobs, J. M.; Gritsenko, M. A.; Camp, D. G.; Bhattacharya, R.; Perkins, J. D.; Carithers, R. L., Jr.; Liou, I. W.; Larson, A. M.; Benecke, A.; Waters, K. M.; Smith, R. D.; Katze, M. G. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation Hepatology 2012, 56 (1) 28-38
55. He, Y.; Nakao, H.; Tan, S. L.; Polyak, S. J.; Neddermann, P.; Vijaysri, S.; Jacobs, B. L.; Katze, M. G. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase J. Virol. 2002, 76 (18) 9207-17
56. Jiang, Y. F.; He, B.; Li, N. P.; Ma, J.; Gong, G. Z.; Zhang, M. The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-kappaB pathways Cell Biol. Int. 2011, 35 (12) 1225-32
57. Pfannkuche, A.; Buther, K.; Karthe, J.; Poenisch, M.; Bartenschlager, R.; Trilling, M.; Hengel, H.; Willbold, D.; Haussinger, D.; Bode, J. G. c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication Hepatology 2011, 53 (4) 1127-36
58. Calderwood, M. A.; Venkatesan, K.; Xing, L.; Chase, M. R.; Vazquez, A.; Holthaus, A. M.; Ewence, A. E.; Li, N.; Hirozane-Kishikawa, T.; Hill, D. E.; Vidal, M.; Kieff, E.; Johannsen, E. Epstein-Barr virus and virus human protein interaction maps Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (18) 7606-11
59. Pichlmair, A.; Kandasamy, K.; Alvisi, G.; Mulhern, O.; Sacco, R.; Habjan, M.; Binder, M.; Stefanovic, A.; Eberle, C. A.; Goncalves, A.; Burckstummer, T.; Muller, A. C.; Fauster, A.; Holze, C.; Lindsten, K.; Goodbourn, S.; Kochs, G.; Weber, F.; Bartenschlager, R.; Bowie, A. G.; Bennett, K. L.; Colinge, J.; Superti-Furga, G. Viral immune modulators perturb the human molecular network by common and unique strategies Nature 2012, 487 (7408) 486-90
60. Huang, H.; Jedynak, B. M.; Bader, J. S. Where have all the interactions gone? Estimating the coverage of two-hybrid protein interaction maps PLoS Comput. Biol. 2007, 3 (11) e214
61. Nordle Gilliver, A.; Griffin, S.; Harris, M. Identification of a novel phosphorylation site in hepatitis C virus NS5A J. Gen. Virol. 2010, 91 (Pt 10) 2428-32
62. Qiu, D.; Lemm, J. A.; O'Boyle, D. R., 2nd; Sun, J. H.; Nower, P. T.; Nguyen, V.; Hamann, L. G.; Snyder, L. B.; Deon, D. H.; Ruediger, E.; Meanwell, N. A.; Belema, M.; Gao, M.; Fridell, R. A. The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization J. Gen. Virol. 2011, 92 (Pt 11) 2502-11
63. Tellinghuisen, T. L.; Foss, K. L.; Treadaway, J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein PLoS Pathog. 2008, 4 (3) e1000032
64. Chen, K. C.; Wang, T. Y.; Chan, C. H. Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles PLoS One 2012, 7 (3) e34240
65. Rozenblatt-Rosen, O.; Deo, R. C.; Padi, M.; Adelmant, G.; Calderwood, M. A.; Rolland, T.; Grace, M.; Dricot, A.; Askenazi, M.; Tavares, M.; Pevzner, S. J.; Abderazzaq, F.; Byrdsong, D.; Carvunis, A. R.; Chen, A. A.; Cheng, J.; Correll, M.; Duarte, M.; Fan, C.; Feltkamp, M. C.; Ficarro, S. B.; Franchi, R.; Garg, B. K.; Gulbahce, N.; Hao, T.; Holthaus, A. M.; James, R.; Korkhin, A.; Litovchick, L.; Mar, J. C.; Pak, T. R.; Rabello, S.; Rubio, R.; Shen, Y.; Singh, S.; Spangle, J. M.; Tasan, M.; Wanamaker, S.; Webber, J. T.; Roecklein-Canfield, J.; Johannsen, E.; Barabasi, A. L.; Beroukhim, R.; Kieff, E.; Cusick, M. E.; Hill, D. E.; Munger, K.; Marto, J. A.; Quackenbush, J.; Roth, F. P.; DeCaprio, J. A.; Vidal, M. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins Nature 2012, 487 (7408) 491-5
66. Barnaba, V. Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival J. Hepatol. 2010, 53 (4) 752-61
67. Hiroishi, K.; Ito, T.; Imawari, M. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence J. Gastroenterol. Hepatol. 2008, 23 (10) 1473-82
68. Kawai, T.; Akira, S. Toll-like receptor and RIG-I-like receptor signaling Ann. N. Y. Acad. Sci. 2008, 1143, 1-20
69. Sklan, E. H.; Charuworn, P.; Pang, P. S.; Glenn, J. S. Mechanisms of HCV survival in the host Nat. Rev. Gastroenterol. Hepatol. 2009, 6 (4) 217-27
70. Kang, S. M.; Won, S. J.; Lee, G. H.; Lim, Y. S.; Hwang, S. B. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment FEBS Lett. 2010, 584 (18) 4069-76
71. Li, K.; Li, N. L.; Wei, D.; Pfeffer, S. R.; Fan, M.; Pfeffer, L. M. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates Hepatology 2012, 55 (3) 666-75
72. Tanaka, S.; Arii, S. Molecularly targeted therapy for hepatocellular carcinoma Cancer Sci. 2009, 100 (1) 1-8
73. Tanaka, S.; Arii, S. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science Int. J. Clin. Oncol. 2010, 15 (3) 235-41
74. Villanueva, A.; Chiang, D. Y.; Newell, P.; Peix, J.; Thung, S.; Alsinet, C.; Tovar, V.; Roayaie, S.; Minguez, B.; Sole, M.; Battiston, C.; Van Laarhoven, S.; Fiel, M. I.; Di Feo, A.; Hoshida, Y.; Yea, S.; Toffanin, S.; Ramos, A.; Martignetti, J. A.; Mazzaferro, V.; Bruix, J.; Waxman, S.; Schwartz, M.; Meyerson, M.; Friedman, S. L.; Llovet, J. M. Pivotal role of mTOR signaling in hepatocellular carcinoma Gastroenterology 2008, 135 (6) 1972-83
75. Cheng, D.; Zhao, L.; Zhang, L.; Jiang, Y.; Tian, Y.; Xiao, X.; Gong, G. p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45alpha expression via the NF-kappaB and PI3K-Akt pathways J. Gen. Virol. 2013, 94 (Pt 2) 326-35
76. Tripathi, L. P.; Kambara, H.; Moriishi, K.; Morita, E.; Abe, T.; Mori, Y.; Chen, Y. A.; Matsuura, Y.; Mizuguchi, K. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28gamma knockout in HCV pathogenesis: a network-based study J. Proteome Res. 2012, 11 (7) 3664-79
77. Zhao, L. J.; Zhao, P.; Chen, Q. L.; Ren, H.; Pan, W.; Qi, Z. T. Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection Cell Proliferation 2007, 40 (4) 508-21
78. Basaranoglu, M.; Basaranoglu, G. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis World J. Gastroenterol. 2011, 17 (36) 4055-62
79. Del Campo, J. A.; Romero-Gomez, M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J. Gastroenterol. 2009, 15 (40) 5014-9
80. Douglas, M. W.; George, J. Molecular mechanisms of insulin resistance in chronic hepatitis C World J. Gastroenterol. 2009, 15 (35) 4356-64
81. Das, G. C.; Hollinger, F. B. Molecular pathways for glucose homeostasis, insulin signaling and autophagy in hepatitis C virus induced insulin resistance in a cellular model Virology 2012, 434 (1) 5-17
82. Miyamoto, H.; Moriishi, K.; Moriya, K.; Murata, S.; Tanaka, K.; Suzuki, T.; Miyamura, T.; Koike, K.; Matsuura, Y. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein J. Virol. 2007, 81 (4) 1727-35
83. Kaneko, K.; Ueki, K.; Takahashi, N.; Hashimoto, S.; Okamoto, M.; Awazawa, M.; Okazaki, Y.; Ohsugi, M.; Inabe, K.; Umehara, T.; Yoshida, M.; Kakei, M.; Kitamura, T.; Luo, J.; Kulkarni, R. N.; Kahn, C. R.; Kasai, H.; Cantley, L. C.; Kadowaki, T. Class IA phosphatidylinositol 3-kinase in pancreatic beta cells controls insulin secretion by multiple mechanisms Cell Metab. 2010, 12 (6) 619-32
84. Milward, A.; Mankouri, J.; Harris, M. Hepatitis C virus NS5A protein interacts with beta-catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion J. Gen. Virol. 2010, 91 (Pt 2) 373-81
85. Alberstein, M.; Zornitzki, T.; Zick, Y.; Knobler, H. Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression J. Viral Hepatitis 2012, 19 (1) 65-71
86. Benedicto, I.; Molina-Jimenez, F.; Bartosch, B.; Cosset, F. L.; Lavillette, D.; Prieto, J.; Moreno-Otero, R.; Valenzuela-Fernandez, A.; Aldabe, R.; Lopez-Cabrera, M.; Majano, P. L. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection J. Virol. 2009, 83 (16) 8012-20
87. Carloni, G.; Crema, A.; Valli, M. B.; Ponzetto, A.; Clementi, M. HCV infection by cell-to-cell transmission: choice or necessity? Curr. Mol. Med. 2012, 12 (1) 83-95
88. Wilson, G. K.; Brimacombe, C. L.; Rowe, I. A.; Reynolds, G. M.; Fletcher, N. F.; Stamataki, Z.; Bhogal, R. H.; Simoes, M. L.; Ashcroft, M.; Afford, S. C.; Mitry, R. R.; Dhawan, A.; Mee, C. J.; Hubscher, S. G.; Balfe, P.; McKeating, J. A. A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration J. Hepatol. 2012, 56 (4) 803-9
89. Daugherty, R. L.; Gottardi, C. J. Phospho-regulation of beta-catenin adhesion and signaling functions Physiology 2007, 22, 303-9
90. Presser, L. D.; Haskett, A.; Waris, G. Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-beta1: role of TGF-beta1 in HCV replication Virology 2011, 412 (2) 284-96
91. Berger, K. L.; Cooper, J. D.; Heaton, N. S.; Yoon, R.; Oakland, T. E.; Jordan, T. X.; Mateu, G.; Grakoui, A.; Randall, G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (18) 7577-82
92. Katsarou, K.; Lavdas, A. A.; Tsitoura, P.; Serti, E.; Markoulatos, P.; Mavromara, P.; Georgopoulou, U. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events Cell. Mol. Life Sci. 2010, 67, 2491-506
93. Mankouri, J.; Griffin, S.; Harris, M. The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor Traffic 2008, 9 (9) 1497-509
94. Diao, J.; Pantua, H.; Ngu, H.; Komuves, L.; Diehl, L.; Schaefer, G.; Kapadia, S. B. Hepatitis C virus (HCV) induces epidermal growth factor receptor (EGFR) activation via CD81 binding for viral internalization and entry J. Virol. 2012, 86 (20) 10935-49
95. Yoon, H. Y.; Kales, S. C.; Luo, R.; Lipkowitz, S.; Randazzo, P. A. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking Biol. Cell 2011, 103 (4) 171-84
96. Katsarou, K.; Lavdas, A. A.; Tsitoura, P.; Serti, E.; Markoulatos, P.; Mavromara, P.; Georgopoulou, U. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events Cell. Mol. Life Sci. 2010, 67 (14) 2491-506
97. Diaz, A.; Ahlquist, P. Role of host reticulon proteins in rearranging membranes for positive-strand RNA virus replication Curr. Opin. Microbiol. 2012, 15 (4) 519-24
98. Diaz, A.; Wang, X.; Ahlquist, P. Membrane-shaping host reticulon proteins play crucial roles in viral RNA replication compartment formation and function Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (37) 16291-6
99. Rahim, A.; Nafi-valencia, E.; Siddiqi, S.; Basha, R.; Runyon, C. C.; Siddiqi, S. A. Proteomic analysis of the very low density lipoprotein (VLDL) transport vesicles J Proteomics 2012, 75 (7) 2225-35
100. Coller, K. E.; Heaton, N. S.; Berger, K. L.; Cooper, J. D.; Saunders, J. L.; Randall, G. Molecular determinants and dynamics of hepatitis C virus secretion PLoS Pathog. 2012, 8 (1) e1002466
101. Lai, C. K.; Jeng, K. S.; Machida, K.; Lai, M. M. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A J. Virol. 2008, 82 (17) 8838-48
102. Randall, G.; Panis, M.; Cooper, J. D.; Tellinghuisen, T. L.; Sukhodolets, K. E.; Pfeffer, S.; Landthaler, M.; Landgraf, P.; Kan, S.; Lindenbach, B. D.; Chien, M.; Weir, D. B.; Russo, J. J.; Ju, J.; Brownstein, M. J.; Sheridan, R.; Sander, C.; Zavolan, M.; Tuschl, T.; Rice, C. M. Cellular cofactors affecting hepatitis C virus infection and replication Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (31) 12884-9
103. Saxena, V.; Lai, C. K.; Chao, T. C.; Jeng, K. S.; Lai, M. M. Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft J. Virol. 2012, 86 (8) 4139-50
104. Quintavalle, M.; Sambucini, S.; Summa, V.; Orsatti, L.; Talamo, F.; De Francesco, R.; Neddermann, P. Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors J. Biol. Chem. 2007, 282 (8) 5536-44
105. Ivanov, A. V.; Tunitskaya, V. L.; Ivanova, O. N.; Mitkevich, V. A.; Prassolov, V. S.; Makarov, A. A.; Kukhanova, M. K.; Kochetkov, S. N. Hepatitis C virus NS5A protein modulates template selection by the RNA polymerase in in vitro system FEBS Lett. 2009, 583 (2) 277-80
106. Park, C. Y.; Choi, S. H.; Kang, S. M.; Kang, J. I.; Ahn, B. Y.; Kim, H.; Jung, G.; Choi, K. Y.; Hwang, S. B. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis J. Hepatol. 2009, 51 (5) 853-64
107. Zhang, Z.; Harris, D.; Pandey, V. N. The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus J. Virol. 2008, 82 (12) 5761-73
108. Chen, Y. J.; Chen, Y. H.; Chow, L. P.; Tsai, Y. H.; Chen, P. H.; Huang, C. Y.; Chen, W. T.; Hwang, L. H. Heat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication J. Biol. Chem. 2010, 285 (36) 28183-90
109. Choi, Y. W.; Tan, Y. J.; Lim, S. G.; Hong, W.; Goh, P. Y. Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein Biochem. Biophys. Res. Commun. 2004, 318 (2) 514-9
110. Ahn, J.; Chung, K. S.; Kim, D. U.; Won, M.; Kim, L.; Kim, K. S.; Nam, M.; Choi, S. J.; Kim, H. C.; Yoon, M.; Chae, S. K.; Hoe, K. L. Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus J. Biochem. Mol. Biol. 2004, 37 (6) 741-8
111. Amako, Y.; Sarkeshik, A.; Hotta, H.; Yates, J., 3rd; Siddiqui, A. Role of oxysterol binding protein in hepatitis C virus infection J. Virol. 2009, 83 (18) 9237-46
112. Lim, Y. S.; Tran, H. T.; Park, S. J.; Yim, S. A.; Hwang, S. B. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation J. Virol. 2011, 85 (17) 8777-88
113. Chen, Y. C.; Su, W. C.; Huang, J. Y.; Chao, T. C.; Jeng, K. S.; Machida, K.; Lai, M. M. Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A J. Virol. 2010, 84 (16) 7983-93
114. Waller, H.; Chatterji, U.; Gallay, P.; Parkinson, T.; Targett-Adams, P. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A J. Virol. Methods 2010, 165 (2) 202-10
115. Chatterji, U.; Lim, P.; Bobardt, M. D.; Wieland, S.; Cordek, D. G.; Vuagniaux, G.; Chisari, F.; Cameron, C. E.; Targett-Adams, P.; Parkinson, T.; Gallay, P. A. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors J. Hepatol. 2010, 53 (1) 50-6
116. Georgopoulou, U.; Tsitoura, P.; Kalamvoki, M.; Mavromara, P. The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein Biochimie 2006, 88 (6) 651-62
117. Helbig, K. J.; Eyre, N. S.; Yip, E.; Narayana, S.; Li, K.; Fiches, G.; McCartney, E. M.; Jangra, R. K.; Lemon, S. M.; Beard, M. R. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A Hepatology 2011, 54 (5) 1506-17
118. Kumthip, K.; Chusri, P.; Jilg, N.; Zhao, L.; Fusco, D. N.; Zhao, H.; Goto, K.; Cheng, D.; Schaefer, E. A.; Zhang, L.; Pantip, C.; Thongsawat, S.; O'Brien, A.; Peng, L. F.; Maneekarn, N.; Chung, R. T.; Lin, W. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling J. Virol. 2012, 86 (16) 8581-91
119. Inubushi, S.; Nagano-Fujii, M.; Kitayama, K.; Tanaka, M.; An, C.; Yokozaki, H.; Yamamura, H.; Nuriya, H.; Kohara, M.; Sada, K.; Hotta, H. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk J. Gen. Virol. 2008, 89 (Pt 5) 1231-42